Clinical Trial Update: SX ELLA Esophageal Degradable BD Stent System [NA]

View source ↗

Summary

Completed clinical trial evaluating the SX ELLA Esophageal Degradable BD Stent System for benign esophageal lesions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Esophageal Lesions

Drugs mentioned

• SX ELLA Esophageal Degradable BD Stent System

Snippet

Sponsor: Cook Group Incorporated | Conditions: Benign Esophageal Lesions | NA | Status: COMPLETED